Published in Pediatrics on July 01, 1991
Recommendations for neonatal surfactant therapy. Paediatr Child Health (2005) 0.92
Surfactant replacement therapy. Thorax (1996) 0.86
The sitting position during neurosurgical procedures does not influence serum biomarkers of pulmonary parenchymal injury. BMC Surg (2012) 0.81
The Role of Surfactant in Lung Disease and Host Defense against Pulmonary Infections. Ann Am Thorac Soc (2015) 0.81
Measurement of protein flux with positron emission tomography in neonates. Arch Dis Child Fetal Neonatal Ed (1999) 0.78
[Not Available]. Paediatr Child Health (2005) 0.75
Fetal and neonatal samples of a precursor surfactant protein B inversely related to gestational age. BMC Pediatr (2013) 0.75
Artificial versus natural surfactant--can we base clinical practice on a firm scientific footing? Eur J Pediatr (1994) 0.75
Monitoring alveolar epithelial function in acute lung injury. J Clin Monit Comput (2000) 0.75
Collaborative quality improvement for neonatal intensive care. NIC/Q Project Investigators of the Vermont Oxford Network. Pediatrics (2001) 2.87
A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. N Engl J Med (1989) 1.99
A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome. Pediatrics (1972) 1.93
Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev (2007) 1.85
Correlation of Dextrostix values with true glucose in the range less than 50 mg/dl. J Pediatr (1975) 1.78
Economic implications of neonatal intensive care unit collaborative quality improvement. Pediatrics (2001) 1.75
Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants <30 weeks' gestation: a randomized, controlled trial. J Perinatol (2012) 1.73
Surfactant inactivation by hyperventilation: conservation by end-expiratory pressure. J Appl Physiol (1975) 1.68
Heroin induction of lung maturation and growth retardation in fetal rabbits. J Pediatr (1973) 1.55
Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev (2000) 1.52
Association between maternal diabetes and the respiratory-distress syndrome in the newborn. N Engl J Med (1976) 1.46
Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics (1996) 1.42
Health and developmental outcomes of a surfactant controlled trial: follow-up at 2 years. Pediatrics (1990) 1.40
Isolation of a cDNA clone encoding a high molecular weight precursor to a 6-kDa pulmonary surfactant-associated protein. J Biol Chem (1987) 1.40
Apnea monitor failure in infants with upper airway obstruction. Pediatrics (1977) 1.39
Sudden infant death syndrome in infants with bronchopulmonary dysplasia. Pediatrics (1982) 1.38
Isolation and characterization of cDNA clones for the 35-kDa pulmonary surfactant-associated protein. J Biol Chem (1986) 1.36
Human SP-A protein variants derived from one or both genes stimulate TNF-alpha production in the THP-1 cell line. Am J Physiol Lung Cell Mol Physiol (2000) 1.29
The effect of epinephrine on tracheal fluid flow and surfactant efflux in fetal sheep. Am Rev Respir Dis (1978) 1.26
A European multicenter randomized controlled trial of single dose surfactant therapy for idiopathic respiratory distress syndrome. Eur J Pediatr (1990) 1.26
Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev (2004) 1.23
Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease. Pediatrics (1987) 1.18
Surfactant protein B: lipid interactions of synthetic peptides representing the amino-terminal amphipathic domain. Proc Natl Acad Sci U S A (1991) 1.18
Studies on organ maturation: "skin age" as an indicator of "lung age" in fetal rabbits. Pediatrics (1972) 1.17
Surfactant protein A stimulation of inflammatory cytokine and immunoglobulin production. Am J Physiol (1994) 1.15
Conformation and molecular topography of the N-terminal segment of surfactant protein B in structure-promoting environments. Protein Sci (1996) 1.13
Biosynthesis and in vitro translation of the major surfactant-associated protein from human lung. J Biol Chem (1985) 1.13
Structure-function relationships of bovine pulmonary surfactant proteins: SP-B and SP-C. Biochim Biophys Acta (1990) 1.12
Isoxsuprine-induced alterations of pulmonary pressure-volume relationships in premature rabbits. Am J Obstet Gynecol (1974) 1.11
The lung of the newborn infant. Sci Am (1973) 1.07
Factors associated with surfactant treatment response in infants with severe respiratory distress syndrome. Pediatrics (1989) 1.06
Vitamin K1 metabolism and the production of des-carboxy prothrombin and protein C in the term and premature neonate. Blood (1993) 1.06
Electrophoretic transfer of proteins from fixed and stained gels. Anal Biochem (1984) 1.04
An electrophoretic and immunochemical characterization of human surfactant-associated proteins. Biochim Biophys Acta (1984) 1.04
Expression of the 35kDa and low molecular weight surfactant-associated proteins in the lungs of infants dying with respiratory distress syndrome. Am J Pathol (1989) 1.03
Sighing in newborn human infants: role of inflation-augmenting reflex. J Appl Physiol (1976) 1.01
Ventilation and sleep states in newborn infants. J Pediatr (1976) 1.01
Glucocorticoid prophylaxis for respiratory distress syndrome: a review of potential toxicity. J Pediatr (1975) 1.00
Surfactant protein A regulates cytokine production in the monocytic cell line THP-1. Am J Physiol (1997) 1.00
Surfactant protein A activates NF-kappa B in the THP-1 monocytic cell line. Am J Physiol (1997) 0.99
Comparison of captive and pulsating bubble surfactometers with use of lung surfactants. J Appl Physiol (1985) (1994) 0.99
Ultrastructure of lung in surfactant protein B deficiency. Am J Respir Cell Mol Biol (1994) 0.98
Both human SP-A1 and Sp-A2 genes are expressed in small and large intestine. Pediatr Pathol Mol Med (2001) 0.98
Defining quality of care indicators for neonatal intensive care units independent of maternal risk factors. J Natl Med Assoc (1990) 0.96
Radiographic findings associated with surfactant treatment. Am J Perinatol (1991) 0.96
Inhibition of lung cell division after hydrocortisone injection into fetal rabbits. J Appl Physiol (1973) 0.95
Immunogold localization of SP-A in lungs of infants dying from respiratory distress syndrome. Am J Pathol (1993) 0.95
Polyethylene glycol/surfactant mixtures improve lung function after HCl and endotoxin lung injuries. Am J Respir Crit Care Med (2001) 0.94
Risk of respiratory distress syndrome after prenatal dexamethasone treatment. Pediatrics (1979) 0.94
Diuretics for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev (2001) 0.93
Comparison of SP-A and LPS effects on the THP-1 monocytic cell line. Am J Physiol Lung Cell Mol Physiol (2000) 0.93
Surfactant for meconium aspiration syndrome in full term/near term infants. Cochrane Database Syst Rev (2007) 0.92
Postnatal stimulation of rat surfactant protein A synthesis by dexamethasone. Am J Physiol (1989) 0.92
Effects of surfactant protein A and surfactant lipids on lymphocyte proliferation in vitro. Am J Physiol (1994) 0.92
Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS. Cochrane Database Syst Rev (2002) 0.92
Surfactant protein-A reduces binding and phagocytosis of pneumocystis carinii by human alveolar macrophages in vitro. Am J Respir Cell Mol Biol (1998) 0.92
Characterization of bovine surfactant for infants with respiratory distress syndrome. Pediatrics (1986) 0.92
Pneumothorax and other forms of pulmonary air leak in newborns. Am Rev Respir Dis (1979) 0.92
Effect of SP-A and surfactant lipids on expression of cell surface markers in the THP-1 monocytic cell line. Am J Physiol (1997) 0.91
Post-translational modification of the major human surfactant-associated proteins. Biochem J (1986) 0.90
Physical, chemical, and physiological characteristics of isolates of pulmonary surfactant from adult rabbits. Can J Physiol Pharmacol (1985) 0.89
Surfactant components modulate fibroblast apoptosis and type I collagen and collagenase-1 expression. Am J Physiol Lung Cell Mol Physiol (2000) 0.88
Interaction of surfactant protein A with lipopolysaccharide and regulation of inflammatory cytokines in the THP-1 monocytic cell line. Infect Immun (2000) 0.86
Characterization and partial amino acid sequence of a low molecular weight surfactant protein. Am Rev Respir Dis (1987) 0.86
Topical ointment for preventing infection in preterm infants. Cochrane Database Syst Rev (2004) 0.86
Current surfactant use in premature infants. Clin Perinatol (2001) 0.85
Variation in mortality and intraventricular haemorrhage in occupants of Pacific Rim nurseries. J Paediatr Child Health (2002) 0.84
Clinical trials of natural surfactant extract in respiratory distress syndrome. Clin Perinatol (1993) 0.84
Reversible and irreversible inactivation of preformed pulmonary surfactant surface films by changes in subphase constituents. Biochim Biophys Acta (1993) 0.83
Maturational effects on respiratory responses to carbon dioxide in premature infants. J Appl Physiol (1976) 0.82
Synthesis, secondary structure and folding of the bend region of lung surfactant protein B. Pept Res (1996) 0.82
Inhibition of mixtures of surfactant lipids and synthetic sequences of surfactant proteins SP-B and SP-C. Biochim Biophys Acta (1991) 0.82
Accelerated lung maturation and increased survival in premature rabbits treated with hydrocortisone. Am Rev Respir Dis (1972) 0.82
Hypothermia for the treatment of infants with hypoxic-ischemic encephalopathy. J Perinatol (2010) 0.82
Regular fetal breathing induced by pilocarpine infusion in the near-term fetal lamb. J Appl Physiol Respir Environ Exerc Physiol (1981) 0.81
Mixtures of low molecular weight surfactant proteins and dipalmitoyl phosphatidylcholine duplicate effects of pulmonary surfactant in vitro and in vivo. Pediatr Res (1988) 0.81
Prediction of risk of bronchopulmonary dysplasia. Am J Perinatol (1983) 0.81
The utility of postmortem lung for RNA studies; variability and correlation of the expression of surfactant proteins in human lung. Exp Lung Res (1991) 0.80
Antibodies against synthetic amphipathic helical sequences of surfactant protein SP-B detect a conformational change in the native protein. FEBS Lett (1991) 0.80
Changes in surfactant protein A mRNA levels in a rat model of insulin-treated diabetic pregnancy. Pediatr Res (1996) 0.80
Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study. J Natl Med Assoc (1994) 0.80
Augmentation of pulmonary surfactant secretion by lung expansion at birth. Pediatr Res (1979) 0.80
Time of onset of necrotizing enterocolitis in newborn infants with known prenatal cocaine exposure. Clin Pediatr (Phila) (1995) 0.80
Pulmonary pressure-volume relationships in premature fetal and newborn rabbits. J Appl Physiol (1974) 0.80
Exogenous surfactant for human lung disease. Current status. Am Rev Respir Dis (1983) 0.79
Respiratory regulation after elastic loading and CO2 rebreathing in normal term infants. J Pediatr (1976) 0.79
Surfactant-associated proteins in tracheal aspirates of infants with respiratory distress syndrome after surfactant therapy. Am Rev Respir Dis (1988) 0.79
Full length synthetic surfactant proteins, SP-B and SP-C, reduce surfactant inactivation by serum. Biochim Biophys Acta (1993) 0.79
Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome. Cochrane Database Syst Rev (2007) 0.79
Superoxide dismutase for preventing chronic lung disease in mechanically ventilated preterm infants. Cochrane Database Syst Rev (2001) 0.79